Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas.
about
Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinomaExpression of vascular endothelial growth factor (VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinomaHomologous mesenchymal stem cells promote the emergence and growth of pulmonary metastases of the rat osteosarcoma cell line UMR-106Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.Impact of lymph node micrometastasis in hilar bile duct carcinoma patients.Expressions of D2-40, CK19, galectin-3, VEGF and EGFR in papillary thyroid carcinomaBortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway.Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosisMetastasis via Peritumoral Lymphatic Dilation in Oral Squamous Cell CarcinomaExpression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumorVascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy.SIRT1 expression is associated with lymphangiogenesis, lymphovascular invasion and prognosis in pN0 esophageal squamous cell carcinoma.Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinomaCrosstalk between angiogenesis and lymphangiogenesis in tumor progression.p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapyImmunohistochemical study of vascular endothelial growth factor-C/vascular endothelial growth factor receptor-3 expression in oral tongue squamous cell carcinoma: Correlation with the induction of lymphangiogenesis.Prognostic value of vascular endothelial growth factor-C and podoplanin mRNA expression in esophageal cancer.The relationship between the expression of VEGF, EGFR, and HER-2 mRNA in esophageal squamous cell carcinoma (ESCC) and clinicopathological features of different ethnic groups in Xinjiang.RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma.The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.Expression and significances of contactin-1 in human gastric cancer.Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patientsCirculating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.Cytokines association with clinical and pathological changes in esophageal squamous cell carcinoma.Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma.Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma.Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas.Correlation between CCR7 expression and lymph node metastatic potential of human tongue carcinoma.Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma.Comparison of two in vivo models for prostate cancer: orthotopic and intratesticular inoculation of LNCaP or PC-3 cells.Association between vascular endothelial growth factor expression and lymph node metastasis in cervical cancer: A meta-analysis.Expression levels of vascular endothelial growth factors a and C in patients with peptic ulcers and gastric cancer.Expression and significance of VEGF-C and FLT-4 in gastric cancer.Influences of angiogenesis and lymphangiogenesis on cancerous invasion in experimentally induced tongue carcinoma.Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.
P2860
Q24656802-BC14256E-1C3A-4E07-B4B3-FFD2E4811FCAQ24805206-BE556321-34CB-49C2-A371-C94CCDC300E2Q33778236-F3E25618-8844-405A-8CBF-75C2CC2DF113Q33868284-43E2481A-05C3-4FEF-9933-E7FBA8FF1C33Q33868494-9F3F4E34-A1A4-4A08-BFDA-DDD78DBA9D49Q33972910-669DF526-2DFA-43A2-882C-A637A3C80E62Q33989444-9BE9A454-D582-4730-88B1-42E850A87F67Q34017710-ADA9EBEF-7855-4FC2-80A6-61DF5DA419F6Q34560457-8C1AA0C0-6B40-4503-906F-0A85E3219A17Q34802847-530EE68D-C431-4A35-9483-C4966919C3CBQ35064517-1B910EB0-37B4-4D0C-AEC9-EA496817B3E7Q35187933-E2E1C51C-1634-4CB2-A742-511A3420E878Q35546301-4D088BC6-94CF-4364-9F1C-2C7FFB449EA5Q35549652-48E5D2C3-4A8B-4801-BCBC-091D463D0417Q35730252-452D38A6-6B20-422A-88A9-426D2D09DAD0Q35784131-82CFFBCC-BC9E-4644-A7C4-D674E7CE3C87Q36085358-971EB518-FE75-42AE-9CF9-C11CC12C89B3Q36336498-BF456D6C-592D-419E-8433-E7F4B76AAAE7Q36400274-87055192-13F9-45B5-A80C-21C5528193FBQ36544139-2428F979-A05E-442A-AF69-ED64E2B31E20Q36589860-045CC2A8-D13A-430A-8517-1CA5474CC4B8Q36611320-B88A0A9A-9CF3-42B7-B73B-8C6084DA489EQ36611550-9DEE4739-8059-4299-B5AC-7A5C256DDB54Q36695451-E9C5A292-4395-46E6-ADAF-3BDDFB433275Q36766051-A1229FFB-2393-4842-BE44-3074260E168DQ37071863-741AD16F-89F0-454B-9602-1FAC409BFBC0Q37156639-D1D4571C-CE1B-41F2-BA9F-94847552BCF2Q37321171-438AFEAC-F643-44AF-AB50-79A90BE7C426Q37424186-5AE1E008-9445-4DD1-97C7-98A223DA1FEEQ38376244-2FA928B1-AF20-4B67-8ACB-DBB11BA0AEEBQ38449285-179949F1-88A2-4672-8BA3-6626BA6D00C8Q38454678-C274B016-7F50-4141-9301-1F0367033398Q39023836-577E91E8-A160-4D53-9ADF-5D951AB3EF91Q39375133-0EA700D3-092D-4890-BAC2-6788BA7E6C83Q40467962-610DA801-641C-4D25-AEC0-F99BE5A7D6C7Q40686865-3BFC55BA-63EC-4627-AD0F-D10701F07FD4Q41695649-3911CA17-65CA-48D9-9EE1-DEF9F3FDCFFAQ42005916-BEA1B348-68C7-4C15-B0D3-EA721CAFFDCBQ45218106-FC81F515-C0C2-4688-B69E-3729D07D17F9Q45752215-2A80D4B4-9CD7-4286-82A6-74D9C92498FC
P2860
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Clinicopathological significan ...... geal squamous cell carcinomas.
@en
type
label
Clinicopathological significan ...... geal squamous cell carcinomas.
@en
prefLabel
Clinicopathological significan ...... geal squamous cell carcinomas.
@en
P2093
P356
P1476
Clinicopathological significan ...... geal squamous cell carcinomas.
@en
P2093
M Yoshihara
N Matsutani
P304
P356
10.1002/IJC.1379
P577
2001-09-01T00:00:00Z